Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Oncotarget|September 3, 2016
Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasmsJennifer B Permuth, Jung Choi, Yoganand Balarunathan, et al.
Nature Communications|August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
The Journal of Molecular Diagnostics : JMD|May 8, 2016
Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant InterpretationKurtis D Davies, Midhat S Farooqi, Mike Gruidl, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/ImmunohistochemistryJefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
JAMA Oncology|January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
Virchows Archiv : an International Journal of Pathology|March 13, 2026
Multicenter evaluation of the Idylla IDH1-2 Mutation Assay Kit for detection of IDH mutational status in gliomaMichael Jansen, Mairead Dorney, Theo F J Kraus, et al.
International Journal of Cancer|September 23, 2014
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer ConsortiumAshley S Felix, Mia M Gaudet, Carlo La Vecchia, et al.
JAMA Oncology|July 24, 2020
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial, Douglas Yee, Angela M DeMichele, et al.
Pageof 6